APA (7th ed.) Citation

Kaneko, A., Kobayashi, N., Miura, K., Matsumoto, H., Somekawa, K., Hirose, T., . . . Miyazawa, N. (2024). Real‐world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non‐small cell lung cancer. Thoracic Cancer, 15(15), 1208. https://doi.org/10.1111/1759-7714.15304

Chicago Style (17th ed.) Citation

Kaneko, Ayami, et al. "Real‐world Evidence of Efficacy of Pembrolizumab Plus Chemotherapy and Nivolumab Plus Ipilimumab Plus Chemotherapy as Initial Treatment for Advanced Non‐small Cell Lung Cancer." Thoracic Cancer 15, no. 15 (2024): 1208. https://doi.org/10.1111/1759-7714.15304.

MLA (9th ed.) Citation

Kaneko, Ayami, et al. "Real‐world Evidence of Efficacy of Pembrolizumab Plus Chemotherapy and Nivolumab Plus Ipilimumab Plus Chemotherapy as Initial Treatment for Advanced Non‐small Cell Lung Cancer." Thoracic Cancer, vol. 15, no. 15, 2024, p. 1208, https://doi.org/10.1111/1759-7714.15304.